JP2011513356A5 - - Google Patents

Download PDF

Info

Publication number
JP2011513356A5
JP2011513356A5 JP2010549109A JP2010549109A JP2011513356A5 JP 2011513356 A5 JP2011513356 A5 JP 2011513356A5 JP 2010549109 A JP2010549109 A JP 2010549109A JP 2010549109 A JP2010549109 A JP 2010549109A JP 2011513356 A5 JP2011513356 A5 JP 2011513356A5
Authority
JP
Japan
Prior art keywords
zinc
trimethoprim
infection
composition according
viral infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010549109A
Other languages
English (en)
Japanese (ja)
Other versions
JP5587215B2 (ja
JP2011513356A (ja
Filing date
Publication date
Priority claimed from GBGB0803948.9A external-priority patent/GB0803948D0/en
Application filed filed Critical
Publication of JP2011513356A publication Critical patent/JP2011513356A/ja
Publication of JP2011513356A5 publication Critical patent/JP2011513356A5/ja
Application granted granted Critical
Publication of JP5587215B2 publication Critical patent/JP5587215B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010549109A 2008-03-03 2009-02-27 併用療法 Expired - Fee Related JP5587215B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0803948.9A GB0803948D0 (en) 2008-03-03 2008-03-03 Combination therapy
GB0803948.9 2008-03-03
PCT/EP2009/052394 WO2009109531A2 (en) 2008-03-03 2009-02-27 Combination therapy

Publications (3)

Publication Number Publication Date
JP2011513356A JP2011513356A (ja) 2011-04-28
JP2011513356A5 true JP2011513356A5 (enExample) 2012-04-12
JP5587215B2 JP5587215B2 (ja) 2014-09-10

Family

ID=39315874

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010549109A Expired - Fee Related JP5587215B2 (ja) 2008-03-03 2009-02-27 併用療法

Country Status (11)

Country Link
US (1) US10045984B2 (enExample)
EP (1) EP2257292B1 (enExample)
JP (1) JP5587215B2 (enExample)
CN (1) CN101998856A (enExample)
CA (1) CA2754281C (enExample)
CY (1) CY1115555T1 (enExample)
DK (1) DK2257292T3 (enExample)
ES (1) ES2507570T3 (enExample)
GB (1) GB0803948D0 (enExample)
PT (1) PT2257292E (enExample)
WO (1) WO2009109531A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2740657C1 (ru) * 2020-05-15 2021-01-19 Общество С Ограниченной Ответственностью "Промомед Рус" Противовирусная композиция
NL2028566B1 (nl) * 2021-06-29 2023-01-09 Simons Care Innovation Group B V Een zinkzout huidpleister en werkwijzen
JP7287730B2 (ja) * 2021-10-12 2023-06-06 ローバル株式会社 ウイルスを不活化可能な高濃度亜鉛末塗料

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4125610A (en) * 1977-07-27 1978-11-14 Bristol-Myers Company Antibacterial compositions
US5637311A (en) * 1995-06-29 1997-06-10 Procyte Corporation Zinc(II) complexes and methods related thereto

Similar Documents

Publication Publication Date Title
JP2009102342A5 (enExample)
JP2013542247A5 (enExample)
JP2010518122A5 (enExample)
JP2004534839A5 (enExample)
JP2008525468A5 (enExample)
JP2002519318A5 (enExample)
JP2007506766A5 (enExample)
JP2005512995A5 (enExample)
JP2009537246A5 (enExample)
JP2009541348A5 (enExample)
JP2013509411A5 (enExample)
JP2013508289A5 (enExample)
EP3848369A1 (en) N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)-phenyl]-acetamide free base hemihydrate, methods of manufacture and uses thereof
ES2333805T3 (es) Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos.
TW201805283A (zh) sGC刺激劑之固體形式
JP2011513356A5 (enExample)
JP2009506978A5 (enExample)
JP2012525358A5 (enExample)
JP2009503097A5 (enExample)
CN101654393A (zh) 作为肝脏保护剂的化合物和组合物
CN102871984A (zh) 一种盐酸去氧肾上腺素口腔速溶膜及其制备方法
MXPA05004990A (es) Parche de inhibidor selectivo de ciclooxigenasa-2.
JP2022508217A (ja) Task-1およびtask-3チャンネル阻害剤を含有する医薬投薬形態の製造方法、ならびに呼吸障害治療におけるその使用
AR045576A1 (es) Composicion farmaceutica que comprende drospirenona y etinilestradiol
JP2009506002A5 (enExample)